{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["6(1)"],"submitter":["Visco C"],"pubmed_abstract":["Lymphoma represents a heterogeneous hematological malignancy (HM), which is characterized by severe immunosuppression. Patients diagnosed of coronavirus disease 2019 (COVID-19) during the course of HM have been described to have poor outcome, with only few reports specifically addressing lymphoma patients. Here, we investigated the clinical behavior and clinical parameters of a large multicenter cohort of adult patients with different lymphoma subtypes, with the aim of identifying predictors of death. The study included 856 patients, of whom 619 were enrolled prospectively in a 1-year frame and were followed-up for a median of 66 days (range 1-395). Patients were managed as outpatient (not-admitted cohort, n = 388) or required hospitalization (n = 468), and median age was 63 years (range 1"],"journal":["Blood advances"],"pagination":["327-338"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC8516438"],"repository":["biostudies-literature"],"pubmed_title":["A prognostic model for patients with lymphoma and COVID-19: a multicentre cohort study."],"pmcid":["PMC8516438"],"pubmed_authors":["Mina R","Visco C","Tosi P","Vallisa D","Massaia M","Guidetti A","Marchesi F","Merli F","Coviello E","Tisi MC","Cairoli R","Penna D","Lanza F","Venditti A","Bruna R","Romano A","La Barbera EO","Arcaini L","Pinto A","Galimberti S","Rigacci L","Ferreri AJM","Scattolin A","Ramadan S","Cattaneo C","Cuneo A","Ladetto M","Corso A","Cavo M","Trentin L","Cilloni D","Della Porta M","Candoni A","Corradini P","Marchetti M","ITA-HEMA-COV investigators","Conconi A","Pilerci S","Cardinali V","Visani G","Busca A","Salvini M","Marcheselli L","Musto P","Tafuri A","Bocchia M","Bertu L","Gherlinzoni F","Turrini M","Bonuomo V","Petrucci L","Passamonti F","Selleri C","Fracchiolla N","Sassone M","Armiento D","Krampera M","Gambacorti-Passerini C"],"additional_accession":[]},"is_claimable":false,"name":"A prognostic model for patients with lymphoma and COVID-19: a multicentre cohort study.","description":"Lymphoma represents a heterogeneous hematological malignancy (HM), which is characterized by severe immunosuppression. Patients diagnosed of coronavirus disease 2019 (COVID-19) during the course of HM have been described to have poor outcome, with only few reports specifically addressing lymphoma patients. Here, we investigated the clinical behavior and clinical parameters of a large multicenter cohort of adult patients with different lymphoma subtypes, with the aim of identifying predictors of death. The study included 856 patients, of whom 619 were enrolled prospectively in a 1-year frame and were followed-up for a median of 66 days (range 1-395). Patients were managed as outpatient (not-admitted cohort, n = 388) or required hospitalization (n = 468), and median age was 63 years (range 1","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Jan","modification":"2026-05-09T01:25:21.853Z","creation":"2022-02-11T15:14:02.113Z"},"accession":"S-EPMC8516438","cross_references":{"pubmed":["34644385"],"doi":["10.1182/bloodadvances.2021005691"]}}